Waypoint Capital Advisors, LLC Danaher Corp Transaction History

Waypoint Capital Advisors, LLC

$407 Million
Q3 2024

A detailed history of Waypoint Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Waypoint Capital Advisors, LLC holds 4,520 shares of DHR stock, worth $1.11 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

4,520

Previous 4,478 0.94%

Holding current value

$1.11 Million

Previous $1.12 Million 12.34%

% of portfolio

0.31%

Previous 0.29%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$239.25 - $280.76 $10,048 - $11,791	42 Added 0.94%	4,520 $1.26 Million
Q2 2024 Jul 25, 2024	BUY	$235.51 - $267.98 $17,898 - $20,366	76 Added 1.73%	4,478 $1.12 Million
Q1 2024 Apr 30, 2024	SELL	$224.58 - $256.19 $1,796 - $2,049	-8 Reduced 0.18%	4,402 $1.1 Million
Q4 2023 Jan 22, 2024	SELL	$185.1 - $233.13 $25,543 - $32,171	-138 Reduced 3.03%	4,410 $1.02 Million
Q3 2023 Oct 25, 2023	BUY	$233.08 - $265.59 $3,263 - $3,718	14 Added 0.31%	4,548 $1.13 Million
Q2 2023 Jul 13, 2023	SELL	$224.99 - $256.14 $2,474 - $2,817	-11 Reduced 0.24%	4,534 $1.09 Million
Q1 2023 Apr 13, 2023	SELL	$239.75 - $277.0 $78,638 - $90,856	-328 Reduced 6.73%	4,545 $1.15 Million
Q4 2022 Jan 23, 2023	BUY	$241.42 - $282.29 $5,311 - $6,210	22 Added 0.45%	4,873 $0
Q3 2022 Oct 17, 2022	SELL	$247.06 - $1507.4 $46,447 - $283,391	-188 Reduced 3.73%	4,851 $1.25 Million
Q2 2022 Jul 18, 2022	BUY	$237.11 - $299.66 $9,484 - $11,986	40 Added 0.8%	5,039 $1.28 Million
Q1 2022 Apr 19, 2022	BUY	$257.27 - $315.76 $51,968 - $63,783	202 Added 4.21%	4,999 $1.47 Million
Q4 2021 Feb 07, 2022	BUY	$292.08 - $329.01 $1.4 Million - $1.58 Million	4,797 New	4,797 $1.58 Million

Others Institutions Holding DHR

# of Institutions

2,439

Shares Held

562M

Call Options Held

3.94M

Put Options Held

4.11M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $179B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waypoint Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waypoint Capital Advisors, LLC with notifications on news.

Account

Waypoint Capital Advisors, LLC Danaher Corp Transaction History